{"result": "(\"entity\"<|>AMERICAN COLLEGE OF CARDIOLOGY<|>ORGANIZATION<|>The American College of Cardiology is a professional organization that provides guidelines and recommendations for cardiovascular care, including management of patients with acute coronary syndromes.)\n##\n(\"entity\"<|>AMERICAN HEART ASSOCIATION<|>ORGANIZATION<|>The American Heart Association is a non-profit organization that focuses on heart and stroke research and education, and collaborates on guidelines for cardiovascular health.)\n##\n(\"entity\"<|>CIRCULATION<|>ORGANIZATION<|>Circulation is a peer-reviewed journal that publishes research and guidelines related to cardiovascular health and disease.)\n##\n(\"entity\"<|>HEART FAILURE<|>EVENT<|>Heart failure is a condition that occurs when the heart is unable to pump sufficiently to maintain blood flow, and is prevalent among individuals with diabetes.)\n##\n(\"entity\"<|>TYPE 2 DIABETES<|>EVENT<|>Type 2 diabetes is a chronic condition that affects the way the body processes blood sugar and is associated with a higher risk of cardiovascular diseases.)\n##\n(\"relationship\"<|>AMERICAN COLLEGE OF CARDIOLOGY<|>CIRCULATION<|>The American College of Cardiology publishes guidelines and research findings in the journal Circulation, which focuses on cardiovascular health.<|>7)\n##\n(\"relationship\"<|>AMERICAN HEART ASSOCIATION<|>CIRCULATION<|>The American Heart Association collaborates with the journal Circulation to disseminate research and guidelines on cardiovascular diseases.<|>7)\n##\n(\"relationship\"<|>HEART FAILURE<|>TYPE 2 DIABETES<|>Individuals with Type 2 diabetes have a higher prevalence of heart failure due to associated cardiovascular risks.<|>8)\n##\n(\"relationship\"<|>HEART FAILURE<|>DIABETES<|>Diabetes significantly increases the risk of developing heart failure, making it a critical concern in cardiovascular health.<|>9)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: factores de riesgo como presión arterial, nivel de colesterol y edad.                               Referencias:\n         C. La reducción de los niveles de colesterol LDL apenas produce beneficio clínico para                             • Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. ACC/AHA Task Force Members, Society for\n              disminuir eventos cardiovasculares en los pacientes con diabetes.                                               Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. 2014 AHA/ACC guideline for the management\n                                                                                                                              of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/\n         D.   Los betabloqueantes no deberían ser utilizados en el tratamiento de un síndrome                                 American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(25):2354.\n              coronario agudo en pacientes con diabetes.                                                                    • Gholap NN, Achana FA, Davies MJ, Ray KK, Gray L, Khunti K. Long-term mortality after acute myocardial infarction among individuals\n                                                                                                                              with and without diabetes: A systematic review and meta-analysis of studies in the post-reperfusion era. Diabetes Obes Metab.\n                                                                                                                              2017;19(3):364-74.\n                                                                                                                            • Lehrke M, Marx N. Diabetes Mellitus and Heart Failure. Am J Cardiol. 2017;120(1S):S37-47.\n         COMENTARIO                                                                                                         • Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, et al. Type 2 diabetes and incidence of\n                                                                                                                              cardiovascular diseases: a cohort study in 1•9 million people. Lancet Diabetes Endocrinol. 2015;3(2):105-13.\n         Las personas con diabetes tienen un riesgo incrementado de complicaciones cardiovas-\n         culares, entre ellas el infarto agudo de miocardio (IAM). Aunque el pronóstico de la enfer-\n         medad coronaria ha mejorado en el contexto de los avances de la cardiología interven-                          54  En pacientes con DM1 se ha demostrado en el estudio DCCT (Diabetes Control\n         cionista,    las personas con diabetes siguen teniendo una mortalidad superior tras un                             and Complications Trial) que la reducción de HbA1c mediante el uso de tratamiento\n         IAM, mediada, en parte, por una afectación vascular más extensa y por un retraso en el                             intensivo reduce las complicaciones microangiopáticas. En el caso de la\n         diagnóstico al cursar con una menor sintomatología. En una revisión sistemática recien-                            macroangiopatía, el estudio EDIC (Epidemiology of Diabetes lnterventions\n         te se    confirma que       continúa     existiendo una mayor mortalidad en los sujetos con            diabe-      and Complications) demostró (señale la opción correcta):\n         tes que presentan un IAM. En este análisis de 10 estudios, que incluyeron 714.780 pa-                              A. Que la mortalidad por cualquier causa en los pacientes con DM1 no se redujo mediante\n         cientes, la mortalidad fue 1,82 veces mayor (hazard ratio [HR] 1,82, intervalo de confianza                            un mejor control metabólico.\n         [IC] al 95% 1,73-1,91) comparado con los sujetos sin diabetes, y un 48% mayor después de\n         ajustar por factores de confusión (HR ajustada 1,48, IC al 95% 1,43-1,53).                                         B. Que la mortalidad derivada de las hipoglucemias fue superior al beneficio en reducción\n                                                                                                                                de mortalidad por cualquier causa.\n         Existen datos clínicos y epidemiológicos sólidos que confirman que la prevalencia de insu-                         C. Que la mortalidad por cualquier causa se redujo en un 33%, tras 27 años de seguimiento,\n         ficiencia cardíaca es muy alta              en  la diabetes, y que el pronóstico de los pacientes con                  en el grupo de tratamiento intensivo en comparación con el grupo de tratamiento\n         insuficiencia cardíaca es           peor   si  tienen diabetes, independientemente de la presencia de                  convencional.\n         otros factores de riesgo cardiovascular o de enfermedad coronaria. Además, en el contexto\n         de un descenso de complicaciones cardiovasculares como el IAM y el ACV, actualmente la                             D.  Que la mortalidad por cualquier causa fue menor en el grupo de tratamiento intensivo,\n         insuficiencia cardíaca, junto con la enfermedad arterial periférica, son las complicaciones vas-                       pero tras 27 años de seguimiento la mortalidad global se igualó en ambos grupos.\n         culares que con mayor frecuencia se observan como presentación inicial.\n         Los pacientes con DM2 tienen una mayor prevalencia de dislipidemia, lo que contribuye al                           COMENTARIO\n         mayor riesgo de enfermedad cardiovascular. Multitud de ensayos clínicos han demostrado los                         El estudio EDIC constituye el seguimiento a largo plazo de la mayor parte de los pacientes\n         beneficios del tratamiento con est\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a chronic condition that increases the risk of cardiovascular complications, including acute myocardial infarction (AMI).)\n##\n(\"entity\"<|>ACUTE MYOCARDIAL INFARCTION<|>EVENT<|>Acute Myocardial Infarction (AMI) is a serious cardiovascular event that individuals with diabetes are at increased risk for.)\n##\n(\"entity\"<|>DCCT<|>ORGANIZATION<|>The Diabetes Control and Complications Trial (DCCT) is a study that demonstrated the benefits of intensive treatment in reducing complications in Type 1 diabetes patients.)\n##\n(\"entity\"<|>EDIC<|>ORGANIZATION<|>The Epidemiology of Diabetes Interventions and Complications (EDIC) study is a long-term follow-up study that assessed the effects of diabetes treatment on mortality rates.)\n##\n(\"entity\"<|>CARDIOLOGY<|>ORGANIZATION<|>Cardiology is the medical specialty that deals with disorders of the heart and blood vessels, and has seen advancements that improve the prognosis of coronary disease.)\n##\n(\"entity\"<|>CARDIOVASCULAR DISEASES<|>EVENT<|>Cardiovascular diseases are a group of disorders of the heart and blood vessels, which are prevalent among individuals with diabetes.)\n##\n(\"relationship\"<|>DIABETES<|>ACUTE MYOCARDIAL INFARCTION<|>Individuals with diabetes have an increased risk of experiencing acute myocardial infarction due to underlying cardiovascular complications.<|>8)\n##\n(\"relationship\"<|>DCCT<|>EDIC<|>The DCCT study provided foundational data that led to the long-term follow-up study EDIC, which assessed the impact of diabetes treatment over time.<|>7)\n##\n(\"relationship\"<|>CARDIOLOGY<|>ACUTE MYOCARDIAL INFARCTION<|>Advancements in cardiology have improved the management and prognosis of acute myocardial infarction, particularly in diabetic patients.<|>6)\n##\n(\"relationship\"<|>CARDIOVASCULAR DISEASES<|>DIABETES<|>Diabetes significantly increases the prevalence of cardiovascular diseases, making it a critical area of study in cardiology.<|>9)\n<|COMPLETE|>"}]}